Industry Segment: Pharmaceutical & Biotech | Word Count: 659 Words

GALWAY, IRELAND--June 12, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The forthcoming sale of Bayer's animal medicines business is attracting the interest of leading European private equity firms in a battle that could see the division fetch up to 8 billion euro ($9 billion).

Within this article: Details bidder line up for Bayer animal division sale, leading products, estimated price, Bayer job cuts, related product line sales, Roundup cancer rulings and financial impact